VP
ELV icon

Verum Partners’s Elevance Health ELV Stock Holding History

Verum Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$580K Buy
1,499
+23
+2% +$8.53K 0.09% 110
2026
Q1 		$432K Buy
+1,476
New +$485K 0.08% 111

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Verum Partners's ELV Position: Q2 2026 in Review

Verum Partners increased its Elevance Health (ELV) stake by 1.6% in Q2 2026, buying an estimated $8.53K and bringing the position to 1,499 shares worth $580K. The position accounts for 0.09% of the portfolio, ranked #110.

Verum Partners first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 331 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Verum Partners held 1,499 shares of Elevance Health worth $580K as of Q2 2026.
  • Verum Partners bought 23 Elevance Health shares in Q2 2026, an estimated $8.53K.
  • Elevance Health made up 0.09% of Verum Partners's portfolio in Q2 2026, its #110 holding.
  • Verum Partners first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 331 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.